Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes

NCT01584323 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01584323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01584323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2012
Completion date
May 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnant state, preterm premature rupture of membranes